Document is current
Any future updates will be listed below
-
Authors
Bolaender, Alexander
Zatorska, Danuta
He, Huazhong
Joshi, Suhasini
Sharma, Sahil
Digwal, Chander S.
Patel, Hardik J.
Sun, Weilin
Imber, Brandon S. https://orcid.org/0000-0002-1281-5915
Ochiana, Stefan O.
Patel, Maulik R.
Shrestha, Liza
Shah, Smit. K.
Wang, Shuo
Karimov, Rashad https://orcid.org/0000-0002-6408-7083
Tao, Hui
Patel, Pallav D.
Martin, Ananda Rodilla
Yan, Pengrong https://orcid.org/0000-0003-0021-6461
Panchal, Palak
Almodovar, Justina
Corben, Adriana
Rimner, Andreas https://orcid.org/0000-0002-1214-3856
Ginsberg, Stephen D. https://orcid.org/0000-0002-1797-4288
Lyashchenko, Serge
Burnazi, Eva
Ku, Anson
Kalidindi, Teja
Lee, Sang Gyu
Grkovski, Milan https://orcid.org/0000-0001-7228-9497
Beattie, Bradley J.
Zanzonico, Pat
Lewis, Jason S. https://orcid.org/0000-0001-7065-4534
Larson, Steve
Rodina, Anna
Pillarsetty, Nagavarakishore https://orcid.org/0000-0002-1750-7436
Tabar, Viviane
Dunphy, Mark P. https://orcid.org/0000-0002-1886-1832
Taldone, Tony
Shimizu, Fumiko https://orcid.org/0000-0003-4107-2871
Chiosis, Gabriela https://orcid.org/0000-0003-0486-6920
- License Information
-
More Information
Article History
Received: 3 August 2020
Accepted: 7 July 2021
First Online: 3 August 2021
Competing interests
: Memorial Sloan Kettering Cancer Center holds the intellectual rights to this portfolio (PCT/US2007/072671, Treatment of neurodegenerative diseases through inhibition of HSP90 and WO2013/009655, Uses of labeled HSP90 inhibitors). Samus Therapeutics Inc, of which G.C. has partial ownership, and is a member of its board of directors, has licensed this portfolio. G.C., T.T., H.H., D.Z., A.R., N.P., S.L., and J.L. are inventors on the licensed intellectual property. All other authors declare no competing interests.
